Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 20:05:49 19/09/2024 BST			5-day change	1st Jan Change
245.09 ^USD	+1.00%		+2.73%	+5.85%

09-06	Veeva Systems: leader in cloud solutions for the life sciences industry
09-04	'Brighter Skies' Ahead for IQVIA As EPS Set to 'Reaccelerate', RBC Capital Says	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Initiates IQVIA Holdings at Outperform With $275 Price Target	09-04	MT
Jefferies Downgrades IQVIA Holdings to Hold From Buy, Adjusts Price Target to $242 From $266	07-24	MT
Analyst recommendations: Colgate, Lockheed Martin, Procter & Gamble, Eli Lilly, Tesla...	07-24
UBS Adjusts IQVIA Holdings Price Target to $300 From $295, Maintains Buy Rating	07-23	MT
HSBC Adjusts Price Target on IQVIA to $290 From $280	07-23	MT
Morgan Stanley Adjusts Price Target on IQVIA Holdings to $280 From $270, Maintains Overweight Rating	07-23	MT
Barclays Adjusts Price Target on IQVIA Holdings to $275 From $255, Maintains Overweight Rating	07-23	MT
Goldman Sachs Adjusts Price Target on IQVIA Holdings to $280 From $270, Maintains Buy Rating	07-23	MT
Baird Adjusts Price Target on IQVIA Holdings to $251 From $235, Maintains Neutral Rating	07-23	MT
Evercore ISI Adjusts Price Target on IQVIA Holdings to $270 From $230, Maintains Outperform Rating	07-23	MT
Truist Adjusts Price Target on IQVIA Holdings to $300 From $292, Maintains Buy Rating	07-23	MT
Stifel Adjusts IQVIA Holdings' Price Target to $312 From $288	07-22	MT
Leerink Partners Adjusts Price Target on IQVIA to $267 From $278, Maintains Outperform Rating	07-15	MT
Baird Adjusts Price Target on IQVIA to $235 From $241	07-10	MT
Evercore ISI Adjusts Price Target on IQVIA Holdings to $230 From $250, Maintains Outperform Rating	07-09	MT
Barclays Lowers Price Target on IQVIA Holdings to $255 From $275	06-27	MT
Baird Adjusts Price Target on IQVIA Holdings to $241 From $245	06-13	MT
Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target	06-06	MT
Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294	05-07	MT
UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating	05-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Analyst Reco.

Filters